Related Experiment Video
Updated: Aug 12, 2026
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Oral vaccination against Porteus mirabilis
British Journal of Experimental Pathology
|August 1, 1976
Summary
Oral proteus vaccines protect mice against Proteus mirabilis infections. Multiple doses offer extended protection and cross-protection against related bacterial species, enhancing vaccine efficacy.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Proteus mirabilis infections pose a significant health concern.
- Developing effective oral vaccines is crucial for combating bacterial pathogens.
Purpose of the Study:
- To evaluate the efficacy of an oral Proteus vaccine in mice.
- To assess the duration and spectrum of protection offered by the vaccine.
Main Methods:
- Mice were administered single or multiple doses of an oral Proteus vaccine.
- Vaccinated mice were challenged with lethal doses of Proteus mirabilis.
- Cross-protection assays were performed using different bacterial strains.
Main Results:
- A single oral dose provided protection by day 4.
- Three doses induced protection for 7 days and partial protection for 8 weeks.
- Bivalent oral vaccine demonstrated cross-protection against various Proteus strains, Pseudomonas aeruginosa, Serratia marcescens, and Providencia species.
Conclusions:
- Oral Proteus vaccines are effective in inducing protective immunity.
- Multiple vaccinations enhance the duration and breadth of protection.
- The vaccine shows potential for broad-spectrum protection against Gram-negative infections.
